Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Autoría

autor: Isabelle Ray-Coquard, David Cibula, Ignace Vergote, Sandro Pignata, Bradley J. Monk, Jalid Sehouli, John Farley, Gopa Iyer, Regina Berger, Kathleen N. Moore, Nicoletta Colombo, Robert L Coleman, Susana Banerjee, Amit M. Oza, Rachel N. Grisham, Gunnar B. Kristensen, Martin K Oehler, Carol Aghajanian, Andrew R Clamp, Christian Marth, Elsa Kalbacher, Mansoor Raza Mirza, Esther Drill, Ignacio Romero, Peter Vuylsteke, Felix Hilpert, Anneke Westermann, Josep M. del Campo, David M. O'Malley, Cristina Churruca